These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Dissecting the CD93-Multimerin 2 interaction involved in cell adhesion and migration of the activated endothelium. Galvagni F; Nardi F; Spiga O; Trezza A; Tarticchio G; Pellicani R; Andreuzzi E; Caldi E; Toti P; Tosi GM; Santucci A; Iozzo RV; Mongiat M; Orlandini M Matrix Biol; 2017 Dec; 64():112-127. PubMed ID: 28912033 [TBL] [Abstract][Full Text] [Related]
23. CD93 is Selectively Expressed on Human Myeloma Cells but Not on B Lymphocytes. Fakhari S; Bashiri H; Ghaderi B; Tari K; Jalili A Iran J Immunol; 2019 Jun; 16(2):142-150. PubMed ID: 31182688 [TBL] [Abstract][Full Text] [Related]
24. Expression of the three myeloid cell-associated immunoglobulin G Fc receptors defined by murine monoclonal antibodies on normal bone marrow and acute leukemia cells. Ball ED; McDermott J; Griffin JD; Davey FR; Davis R; Bloomfield CD Blood; 1989 May; 73(7):1951-6. PubMed ID: 2469504 [TBL] [Abstract][Full Text] [Related]
25. C-type lectin domain group 14 proteins in vascular biology, cancer and inflammation. Khan KA; McMurray JL; Mohammed F; Bicknell R FEBS J; 2019 Sep; 286(17):3299-3332. PubMed ID: 31287944 [TBL] [Abstract][Full Text] [Related]
26. Identify the immune characteristics and immunotherapy value of CD93 in the pan-cancer based on the public data sets. Guo A; Zhang J; Tian Y; Peng Y; Luo P; Zhang J; Liu Z; Wu W; Zhang H; Cheng Q Front Immunol; 2022; 13():907182. PubMed ID: 36389798 [TBL] [Abstract][Full Text] [Related]
27. Decrease in CD93 (C1qRp) expression in a human monocyte-like cell line (U937) treated with various apoptosis-inducing chemical substances. Ikewaki N; Tamauchi H; Inoko H Microbiol Immunol; 2007; 51(12):1189-200. PubMed ID: 18094537 [TBL] [Abstract][Full Text] [Related]
28. Leukocyte immunoglobulin-like receptor B1 and B4 (LILRB1 and LILRB4): Highly sensitive and specific markers of acute myeloid leukemia with monocytic differentiation. Churchill HRO; Fuda FS; Xu J; Deng M; Zhang CC; An Z; Zhang N; Chen P; Bergstrom C; Kansagra A; Collins R; John S; Koduru P; Chen W Cytometry B Clin Cytom; 2021 Jul; 100(4):476-487. PubMed ID: 32918786 [TBL] [Abstract][Full Text] [Related]
29. Role of CD93 in Health and Disease. Tossetta G; Piani F; Borghi C; Marzioni D Cells; 2023 Jul; 12(13):. PubMed ID: 37443812 [TBL] [Abstract][Full Text] [Related]
30. Murine CD93 (C1qRp) contributes to the removal of apoptotic cells in vivo but is not required for C1q-mediated enhancement of phagocytosis. Norsworthy PJ; Fossati-Jimack L; Cortes-Hernandez J; Taylor PR; Bygrave AE; Thompson RD; Nourshargh S; Walport MJ; Botto M J Immunol; 2004 Mar; 172(6):3406-14. PubMed ID: 15004139 [TBL] [Abstract][Full Text] [Related]
31. Human C1qRp is identical with CD93 and the mNI-11 antigen but does not bind C1q. McGreal EP; Ikewaki N; Akatsu H; Morgan BP; Gasque P J Immunol; 2002 May; 168(10):5222-32. PubMed ID: 11994479 [TBL] [Abstract][Full Text] [Related]
32. Identification of human CD93 as the phagocytic C1q receptor (C1qRp) by expression cloning. Steinberger P; Szekeres A; Wille S; Stöckl J; Selenko N; Prager E; Staffler G; Madic O; Stockinger H; Knapp W J Leukoc Biol; 2002 Jan; 71(1):133-40. PubMed ID: 11781389 [TBL] [Abstract][Full Text] [Related]
33. Modulated interaction of the ERM protein, moesin, with CD93. Zhang M; Bohlson SS; Dy M; Tenner AJ Immunology; 2005 May; 115(1):63-73. PubMed ID: 15819698 [TBL] [Abstract][Full Text] [Related]
34. CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia. Wang J; Chen S; Xiao W; Li W; Wang L; Yang S; Wang W; Xu L; Liao S; Liu W; Wang Y; Liu N; Zhang J; Xia X; Kang T; Chen G; Cai X; Yang H; Zhang X; Lu Y; Zhou P J Hematol Oncol; 2018 Jan; 11(1):7. PubMed ID: 29316944 [TBL] [Abstract][Full Text] [Related]
35. Fas receptor-Fas ligand system is independent of both CD34 status and chemosensitivity in acute myeloid leukemia. Lewis NR; Pallis M; Russell NH Exp Hematol; 2000 May; 28(5):535-42. PubMed ID: 10812243 [TBL] [Abstract][Full Text] [Related]
36. CD93/AA4.1: a novel regulator of inflammation in murine focal cerebral ischemia. Harhausen D; Prinz V; Ziegler G; Gertz K; Endres M; Lehrach H; Gasque P; Botto M; Stahel PF; Dirnagl U; Nietfeld W; Trendelenburg G J Immunol; 2010 Jun; 184(11):6407-17. PubMed ID: 20439917 [TBL] [Abstract][Full Text] [Related]
37. Soluble CD93 is an apoptotic cell opsonin recognized by α Blackburn JWD; Lau DHC; Liu EY; Ellins J; Vrieze AM; Pawlak EN; Dikeakos JD; Heit B Eur J Immunol; 2019 Apr; 49(4):600-610. PubMed ID: 30656676 [TBL] [Abstract][Full Text] [Related]